LPA1 receptor antagonist 1 is the most selective nonlipid LPA1 antagonist so far reported
Sunitinib (20-80 mg/kg/day) exhibits broad and potent dose-dependent anti-tumor activity against a variety of tumor xenograft models including HT-29
WO2016090050A1
an orally available inhibitor of the RSV fusion (RSV-F) protein
and modulation of insulin secretion by pancreatic beta-cells
Kaempferol 3-O-gentiobioside Catalog No.:M27149-C LPA1 receptor antagonist 1 isKaempferol 3 O gentiobioside is a flavonoid isolated from C. alata leaves with antidiabetic activity. Kaempferol 3 O gentiobioside possesses activity against glucosidase and displays carbohydrate enzyme inhibitory effect with an IC50 of 50. 0 M. Product information CAS Number: 22149 35 5 Molecular Weight: 610. 52 Formula: C27H30O16 Chemical Name: 5,7 dihydroxy 2 (4 hydroxyphenyl) 3 {[(2S,3R,4S,5S,6R) 3,4,5 trihydroxy 6 ({[(2R,3R,4S,5S,6R) 3,4,5